News

“The gift that clinical trial participation gives—not only to science but to our patients—should not be limited by language,” says Sadie Gabler, director of the University of Utah Office of Research Participant Advocacy. She explains why clinical trial translation and interpretation services are a crucial part of the effort to reduce health disparities.

Amyloidosis is a rare disease and researchers are trying to find new treatments for the disease. Huntsman Cancer Institute's Amandeep Godara, MBBS, tells you more about the disease, including its causes, symptoms and possible treatments.

A cyclotron manufactures radiopharmaceuticals for positron emission tomography (PET) scans, which help doctors see where cancer is located inside the body. Huntsman Cancer Institute director of cyclotron operations, Brandon Buckway, explains how the cyclotron is a crucial tool in treating people with cancer.

Max Rosett faced melanoma as a young adult and a decade later, he is cancer free. He describes how he felt after being diagnosed, the outstanding treatment he received at Huntsman Cancer Institute and the revolutionary immunotherapy clinical trials that helped save his life.

Adriana Coletta, PhD, MS, RD, discusses the amazing new work being done for metastatic prostate cancer patients, what the future of exercise cancer research could look like, and her violin skills in the latest Talks with Docs.

Huntsman Cancer Institute highlights two examples of clinical trials at HCI exploring new innovations in cancer, including the I-SPY2 trial, studying new approaches for breast cancer treatment, and the SWOG CLL Study S1925, or EVOLVE CLL, an international study evaluating a new approach to chronic lymphocytic leukemia or small lymphocytic lymphoma.

Clinical trials bring hope to patients in the form of innovative treatments. During the COVID-19 pandemic, despite strict hospital safety protocols and staff switching to remote work, HCI clinical research teams found a way to make sure patients could safely enroll and stay on clinical trials—remaining steadfast in our commitment to bring promising research advances to patients.

An international group of cancer clinical research experts reported new recommendations that receiving a COVID-19 vaccination should not preclude a cancer patient from participating on a clinical trial. Huntsman Cancer Institute physician-scientist and professor of internal medicine at the University of Utah, Neeraj Agarwal, MD, was part of this newly formed group who reviewed the data and provided recommendations to patients, doctors, research centers, and the pharmaceutical research industry on this critical, emerging issue.